妇科癌症中的激素替代疗法:瘤安全性和替代疗法
Ana Luzarraga Aznar1, Osnat Elyashiv2, Susan Dababou3
1Universitat Autònoma de Barcelona, Vall d'Hebron University Hospital, Department of Gynecologic Oncology, Barcelona, Spain; Tel Aviv University, Faculty of Medical and Health Sciences, Edith Wolfson Medical Center, Division of Gynecologic Oncology, Tel Aviv, Israel.
概括
激素替代疗法对许多妇科癌症幸存者来说是安全的,但风险因癌症类型和阶段而异. 对于那些有禁忌的人来说,存在替代方案,平衡症状缓解与瘤安全.
科学领域:
- 妇科瘤学 妇科瘤学
- 生殖内分泌学 生殖内分泌学
- 癌症的生存率 癌症的生存率
背景情况:
- 妇科癌症治疗通常会导致更年期,影响幸存者的生活质量.
- 激素替代疗法 (HRT) 对更年期症状有效,但其在癌症幸存者的瘤安全性仍在争论中.
- 越来越多的妇科癌症幸存者需要了解HRT的安全性和替代方案.
研究的目的:
- 在各种妇科癌症和遗传性癌症综合征的幸存者中全面审查HRT的安全性.
- 确定特定的妇科癌症亚型和阶段,在这些阶段,HRT被认为是安全的或禁用的.
- 评估非系统性荷尔蒙和非荷尔蒙替代品在高风险幸存者的更年期症状管理中的有效性.
主要方法:
- 对妇科癌症幸存者的HRT安全性研究的综合文献综述.
- 对不同类型的妇科癌症 (子宫内膜,卵巢,宫,,阴道) 和子宫瘤的HRT安全数据的分析.
- 对非全身性荷尔蒙和非荷尔蒙疗法用于更年期症状管理的证据的评估.
主要成果:
- 系统性HRT被认为对低风险的早期子宫内膜癌,大多数卵巢癌,宫癌和/阴道癌是安全的.
- 治疗HRT的禁忌包括晚期/非子宫内膜腺癌,子宫肉瘤和特定的卵巢癌 (例如,颗粒细胞瘤).
- 非全身激素 (阴道雌激素,奥斯佩米芬,DHEA) 和非激素疗法 (滑剂,激光疗法,CBT, gabapentin,fezolinetant,SSRI/SNRIs) 是有效的替代方案.
结论:
- 在妇科癌症幸存者的个性化HRT决策需要平衡瘤安全与生活质量.
- 在精选的妇科癌症幸存者中,HRT可以安全地使用,而替代品对于高风险病例至关重要.
- 有效地管理更年期症状对于这种患者群体的长期健康和福祉至关重要.
相关概念视频
Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Menopause
3.5K
Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
3.5K
Hormonal Control of the Ovarian Cycle
6.3K
The ovarian cycle is meticulously regulated by the hypothalamic-pituitary-gonadal axis. This cycle orchestrates the release of a mature oocyte, essential for reproduction.
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
6.3K
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
Cancer Vaccines
929
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
929


